<DOC>
	<DOCNO>NCT02417506</DOCNO>
	<brief_summary>The repetitive motion associate active life many sport increase wear tear joint lead decrease flexibility joint pain finally head way osteoarthritis . Activities jump , run wear away cartilage support cushion joint hand knee , cause bone rub . Injuries stem repetitive motion also cause worsen joint pain . Joint pain discomfort arise joint . Irrespective underlying mechanism , joint pain usually originate activation nociceptors , free nerve ending . Complex neuronal activation occur , involve local sensitization joint nociceptors also modification central pain pathway . Even though , numerous pharmacological intervention available joint pain , much debate amongst clinicians best approach treatment joint pain . NSAIDs frequently use treatment case , carry concern relate gastro-intestinal system , cardiovascular system well central nervous system . Hence need safer alternative treatment option relieve acute joint pain comparable modern medicine , without pose concern subject 's general well . Herbs know use since age traditional literature pose potential health concern . Inspite positive attribute herbs employ treatment acute pain lack evidence prove . In order address need hour Enovate Biolife invent novel poly herbal formulation E-OA-07 ( Lanconone ) . Lanconone study previously patient osteoarthritis proven efficacious . It good history marketing sell United States , report adverse event related product . However concrete evidence prove product 's acute pain relieve dynamic , hence current study employ comprehend effect lanconone joint acute pain .</brief_summary>
	<brief_title>Study Assess Effect E-OA-07 Acute Pain Response Subjects Suffering From Knee OA</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Ambulatory adult either sex age 40 60 year . Subjects moderate OA knee , clinically , categorize ARA functional Class II III radiological confirmation Kellgren Lawrence Grade II III . ( incase bilateral OA , knee severe symptom define index joint ) Subjects OA flare state baseline define one follow category flare : In subject receive non steroidal antiinflammatory drug ( NSAIDs ) analgesic therapy OA , flare define least two follow three criterion compare screen baseline : 1 . Subject 's assessment arthritis pain VAS walk flat surface baseline ≥ 40 mm ; 2 . Increase ≥ 1 grade patient global assessment arthritis ; 3 . Increase ≥ 1 grade physician 's global assessment arthritis ; In subject receive NSAID analgesic therapy , OA flare state define least two follow three criterion 1 . Subject 's assessment arthritis pain VAS walk flat surface baseline ≥ 40 mm 2 . Patient 's global assessment arthritis `` poor '' ; poor 3 . Physician 's global assessment arthritis `` poor '' ; poor Subjects form arthritis osteoarthritis . Administration intraarticular oral steroid past 3 month intra articular hyaluronic acid last 9 month parenteral use NSAIDs History major chronic hepatic , cardiovascular , neurological immunosuppressive condition presence infection Subjects localized trauma lower limb Had receive oral , intramuscular , intraarticular corticosteroid within 8 week , intraarticular hyaluronic acid index joint within 6 month study drug administration ; Subjects nutritional supplement herbal product since last one month Subjects otherwise judge investigator inappropriate inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Acute pain</keyword>
	<keyword>Herbal</keyword>
	<keyword>VAS</keyword>
	<keyword>Stop watch</keyword>
</DOC>